RxDoctor Payments Data

Ivan Luptak, MD

Cardiovascular Disease · Boston, MANPI 1962650853

Payments from drug & device makers

$279,838in general payments, 2019–2025

Across 2 payments — averaging $139,919 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$280K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen2$279,838

How this compares

$279,838 in reported general payments places this provider in the 90th percentile of 750 cardiovascular disease providers in Massachusetts.

See all cardiovascular disease providers in Massachusetts

Medicare billing

Part B allowed, 2024
$27,012
Medicare patients
169
Services billed
284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin97$81,420
EntrestoSacubitril/Valsartan23$28,551
FarxigaDapagliflozin Propanediol18$14,938
Metoprolol Succinate55$1,107
Atorvastatin Calcium35$448
Torsemide13$378
Losartan Potassium45$351
Spironolactone43$342
Furosemide38$324
Lisinopril31$186
Carvedilol22$167
Amlodipine Besylate19$92

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →